Tumor Necrosis Correlates with PD-L1 and PD-1 Expression in Lung Adenocarcinoma

被引：0
|
作者：
Moldvay, J. [1 ]
Teglasi, V. [2 ]
Pipek, O. [3 ]
Rojko, L. [4 ]
Glasz, T. [2 ]
Vagvolgyi, A. [4 ]
Kovalszky, I. [2 ]
Gyulai, M. [5 ]
Lohinai, Z. [4 ]
Raso, E. [2 ]
Timar, J. [2 ]
Dome, B. [4 ]
Szallasi, Z. [2 ]
Reiniger, L. [2 ]
机构：
[1] Natl Koranyi Inst Pulmonol, Dept Tumor Biol, Budapest, Hungary
[2] Semmelweis Univ, Budapest, Hungary
[3] Elte, Budapest, Hungary
[4] Natl Koranyi Inst Pulmonol, Budapest, Hungary
[5] Cty Hosp Pulmonol, Torokbalint, Hungary
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
PD-L1; lepidic growth pattern; tumor necrosis;
D O I：
10.1016/j.jtho.2019.08.1053
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.09-24
引用
收藏
页码：S505 / S505
页数：1
相关论文
共 50 条
  • [1] PD-L1 Expression in Lymphovascular Tumor Emboli in Lung Adenocarcinoma
    Yeh, Y.
    Ma, H.
    Ho, H.
    Chou, T.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S446 - S446
  • [2] PD-L1 expression and PD-1/PD-L1 inhibitors in breast cancer
    Monneur, Audrey
    Goncalves, Anthony
    Bertucci, Francois
    BULLETIN DU CANCER, 2018, 105 (03) : 261 - 272
  • [3] Tumor-derived exosomal PD-L1: a new perspective in PD-1/PD-L1 therapy for lung cancer
    Wu, Yunjiao
    Fu, Huichao
    Hao, Jingwei
    Yang, Zhaoyang
    Qiao, Xinyi
    Li, Yingjie
    Zhao, Rui
    Lin, Tie
    Wang, Yicun
    Wang, Meng
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [4] Prediction of Responsiveness to PD-L1/PD-1 Inhibitors Using miRNA Profiles Associated With PD-L1 Expression in Lung Adenocarcinoma and Squamous Cell Carcinoma
    Koh, Young wha
    Han, Jae-ho
    Haam, Seokjin
    Lee, Hyun woo
    ANTICANCER RESEARCH, 2024, 44 (05) : 2081 - 2089
  • [5] The Positive Expression of PD-L1/PD-1 in Gastroenteropancreatic Neuroendocrine Neoplasias Correlates with Prognosis
    Yinying, W.
    Chuying, W.
    NEUROENDOCRINOLOGY, 2017, 105 : 141 - 141
  • [6] Regulation of PD-1/PD-L1 pathway and resistance to PD-1/PD-L1 blockade
    Bai, Jie
    Gao, Zhitao
    Li, Xiang
    Dong, Liang
    Han, Weidong
    Nie, Jing
    ONCOTARGET, 2017, 8 (66) : 110693 - 110707
  • [7] Basal cell carcinoma: PD-L1/PD-1 checkpoint expression and tumor regression after PD-1 blockade
    Lipson, Evan J.
    Lilo, Mohammed T.
    Ogurtsova, Aleksandra
    Esandrio, Jessica
    Xu, Haiying
    Brothers, Patricia
    Schollenberger, Megan
    Sharfman, William H.
    Taube, Janis M.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [8] Highly Activated PD-1/PD-L1 Pathway in Gastric Cancer with PD-L1 Expression
    Saito, Hiroaki
    Kono, Yusuke
    Murakami, Yuki
    Shishido, Yuji
    Kuroda, Hirohiko
    Matsunaga, Tomoyuki
    Fukumoto, Yoji
    Osaki, Tomohiro
    Ashida, Keigo
    Fujiwara, Yoshiyuki
    ANTICANCER RESEARCH, 2018, 38 (01) : 107 - 112
  • [9] PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy
    Liu, Jinhua
    Chen, Zichao
    Li, Yaqun
    Zhao, Wenjie
    Wu, JiBiao
    Zhang, Zhen
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [10] PD-1/PD-L1 inhibitors
    Sunshine, Joel
    Taube, Janis M.
    CURRENT OPINION IN PHARMACOLOGY, 2015, 23 : 32 - 38
12345